General Information of DME (ID: DE8RYV5)

DME Name NADPH:quinone reductase (CRYZ) DME Info
Gene Name CRYZ

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [1]
------------------------------------------------------------------------------------
5 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
1,2-NAPHTHOQUINONE DMYXELH Discovery agent N.A. Investigative [2]
4-hydroxy-2-nonenal DM2LJFZ Discovery agent N.A. Investigative [3]
Acetyl ethylene DMUH4N7 N. A. N. A. Investigative [3]
Hexylacrolein DMBC8KM N. A. N. A. Investigative [3]
J-009747 DMQSB6N N. A. N. A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Role of glutathione reductase during menadione-induced NADPH oxidation in isolated rat hepatocytes. Biochem Pharmacol. 1987 Nov 15;36(22):3879-84.
2 Effect of superoxide dismutase on the autoxidation of various hydroquinones--a possible role of superoxide dismutase as a superoxide:semiquinone oxidoreductase. Free Radic Biol Med. 1988;5(2):71-9.
3 Kinetic and structural evidence of the alkenal/one reductase specificity of human crystallin. Cell Mol Life Sci. 2011 Mar;68(6):1065-77.